American Association for the Study of Liver Diseases and the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Course, Part 2: Biliary Atresia—Emerging Diagnostic and Therapeutic Opportunities

Nov 07 2026
Convention Center: Bluebird Ballroom 3DEF
9:45 AM - 10:45 AM
Captured/recorded session Recorded
CE Credits CE Credits

World Class Speakers

Sarah Taylor

Presenter
ST

Sanjiv Harpavat

Presenter
SH

Emmanuel M Gonzales

Presenter
Emmanuel M Gonzales, MD, PhD

Cara L Mack

Presenter
Cara L Mack, MD, MD, FAASLD

Debora Kogan-Liberman

Moderator
Debora Kogan-Liberman, MD

Description

Jointly planned by the American Association for the Study of Liver Diseases and the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition, this educational course highlights advances in understanding the disease mechanism, early diagnostic tools, possible prognostic biomarkers for biliary atresia.  

Presentations

9:45 AM - 10:00 AM
Convention Center - Bluebird Ballroom 3DEF
Recorded session

Updates on the Disease Mechanism in Biliary Atresia

Sarah Taylor | Presenter
10:00 AM - 10:15 AM
Convention Center - Bluebird Ballroom 3DEF
Recorded session

Strategies for Early Diagnosis of Biliary Atresia

Sanjiv Harpavat, MD, PhD | Presenter
10:15 AM - 10:30 AM
Convention Center - Bluebird Ballroom 3DEF
Recorded session

More Than Just Bilirubin: Prognostic Biomarkers in Biliary Atresia

Emmanuel M Gonzales, MD, PhD | Presenter
10:30 AM - 10:45 AM
Convention Center - Bluebird Ballroom 3DEF
Recorded session

Emerging Therapy Opportunities Post Kasai: Is There a Role for Steroids, Antibiotics, or Other Treatments?

Cara L Mack, MD, MD, FAASLD | Presenter

Objectives

  • Review updates in biliary atresia disease mechanism.
  • Discuss new tools for early diagnosis of biliary atresia.
  • Describe advances in prognostic biomarkers and therapies in biliary atresia.

Copyright © 2026 American Association for the Study of Liver Diseases

AASLD 2026